atai Life Sciences, a NASDAQ-listed clinical-stage biopharmaceutical company, will be participating in the Jefferies Global Healthcare Conference in New York. Scheduled for June 6, 2024, at 10:00 A.M. ET, the company’s management will engage in a Fireside Chat and one-on-one investor meetings.
The live webcast of this session will be accessible on the atai website’s Investors section under Events, with a replay available post-event. This engagement underscores atai’s ongoing commitment to addressing the critical needs in mental health treatment through innovative therapeutics aimed at depression, anxiety, addiction, and other mental disorders.
For further details, visit www.atai.life or contact atai directly through their investor relations at IR@atai.life or media inquiries at PR@atai.life.